Wellness Wants In on the Ozempiconomy

Where big pharma goes, the wellness industry follows closely behind. Next stop: GLP-1 receptor agonists.

Called glucagon-like peptide-1 in full, the term “GLP-1″ on a supplement bottle would likely have confused the average shopper a few years ago. But that was before the rise of medications like Ozempic and Wegovy, the brand names for semaglutide, which mimics the hormone GLP-1 that reduces feelings of hunger. Originally prescribed for type 2 diabetics, semaglutide can also slow…